Why Healthcare Stocks Are Primed to Outperform the Market: 2 Firms
Healthcare stocks are typically seen as defensive investments. When things go south for the market, they outperform. That…
Healthcare stock that sees 22–25% revenue growth in H2 FY26 despite global challenges
Synopsis: Poly Medicure expects a strong H2 rebound with 22–25% growth, improved exports, and FY26 revenue growth of…